52
Solaris Endovascular raises $10M in first capital round from Dallas biotech startup
Company raise · Raising · DALLAS, TX · Form D filed 2026-10-01
Solaris Endovascular, a Delaware corporation incorporated in 2024, is raising $10M under Regulation D exemption 06b. The company has sold $4.97M to 45 investors so far with a $3K minimum investment.
Note: Company incorporated in 2024 and filing first Form D in October 2026; no placement agent listed despite $10M raise.
$10M+ raiseFirst raise on EDGARoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Randolph W. Hubbell | Executive Officer, Director |
| Alexander Marra Moreira | Director |
| Melchiades de Cunha Neto | Director |
| Marco Costa | Director |
| David Stack | Director |
| Matthew Head | Executive Officer |
Signed by Giles D. Beal IV, by POA from Randolph W. Hubbell, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.